Specialized Research Focus Gateway Institute for Brain Research operates within the neuroscience research sector, focusing on innovative clinical trials for Parkinson's disease, presenting opportunities for partners specializing in research tools, medical devices, and biotech solutions tailored to neurological disorders.
Growing Financial Size With an estimated revenue between 10 and 25 million dollars and a relatively small team of 11 to 50 employees, the company is positioned for scalable collaborations and technology integrations that can support expanding research initiatives.
Technology Integration Utilizing advanced web and security technologies like Wix, Sentry, and Envoy indicates a modern digital infrastructure, suggesting openness to adopting innovative software solutions for research management, data security, and collaboration needs.
Funding & Expansion Potential While recent funding details are unspecified, the company's active clinical trials and comparable institutes suggest opportunities for funding agencies or investors interested in neuroscience research to support and expand their projects.
Partnership Opportunities The company's focus on clinical trials and collaboration with research institutions opens doors for strategic partnerships, including data analysis, clinical support, and technology development to enhance their neuroscience research capabilities.
$50M$100M
$10M$25M
$50M$100MGateway Institute for Brain Research uses 8 technology products and services including Wix, Module Federation, Sentry, and more. Explore Gateway Institute for Brain Research's tech stack below.
| Gateway Institute for Brain Research Email Formats | Percentage |
| FLast@gifbr.com | 47% |
| First.Last@gifbr.com | 3% |
| First@gifbr.com | 3% |
| FLast@gifbr.com | 47% |
Research ServicesFlorida, United States11-50 Employees
Two exciting clinical trials that address Parkinson's disease from the Gateway Institute for Brain Research. Microbiota Intervention to Change the Response of Parkinson's Disease (MICRO-PD) https://clinicaltrials.gov/ct2/show/NCT03575195 Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease (NOSE-PD) https://clinicaltrials.gov/ct2/show/NCT05266417
Company Overview
Funding & FinancialsGateway Institute for Brain Research's revenue is estimated to be in the range of $10M$25M
Funding & FinancialsGateway Institute for Brain Research's revenue is estimated to be in the range of $10M$25M
1-888-653-2347 
support@leadiq.com